<- Go Home

Abacus Health Products, Inc.

Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils. It provides CBDMEDIC line of products, such as active sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints. The company also offers CBDMEDIC line of therapeutic skincare products, such as medicated ointment for itches, rashes, and eczema; medicated cream for acne treatment; and foaming facial cleanser. Further, it provides Harmony Hemp products, including HempBath, NeuroComfort, and Flexible for personal skincare and OTC topicals through grocery chains. In addition, the company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other CBD products addressing additional medical indications and the health and wellness sectors. The company is headquartered in Toronto, Canada. Abacus Health Products, Inc. operates as a subsidiary of Abacus Products, Inc.

Market Cap

CAD 103.7M

Volume

38.2K

Cash and Equivalents

CAD 17.3M

EBITDA

-CAD 19.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CAD 7.6M

Profit Margin

51.08%

52 Week High

CAD 8.12

52 Week Low

CAD 1.22

Dividend

N/A

Price / Book Value

3.11

Price / Earnings

-14.98

Price / Tangible Book Value

3.59

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-CAD 19.3M

Return on Equity

35.16%

Return on Assets

-40.26

Cash and Short Term Investments

CAD 17.4M

Debt

CAD 381.0K

Equity

CAD 33.3M

Revenue

CAD 15.0M

Unlevered FCF

-CAD 19.1M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches